MacroGenics Announces Achievement of $15 Million Milestone Related to Gilead’s Nomination of a Bispecific Research Program
Go back to MacroGenics Announces Achievement of $15 Million Milestone Related to Gilead’s Nomination of a Bispecific Research Program| MACROGENICS (NASDAQ: MGNX) | Delayed: 4.34 -0.06 (1.36%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.40 | 52 Week High | $36.11 | |||
| Open | $4.29 | 52 Week Low | $14.84 | |||
| Day High | $4.43 | P/E | 11.13 | |||
| Day Low | $4.11 | EPS | $0.39 | |||
| Volume | 159,290 | |||||

